USE OF CD9 FOR A TARGET PROTEIN TO DEVELOP ANTICANCER DRUG OF SOLID CANCERS THAT OVEREXPRESS CD9

摘要

Disclosed is the use of CD9 for a target protein to develop an anticancer agent of solid cancer that overexpresses CD9. Since CD9 is overexpressed in solid cancer cells and functions to augment cell viability, invasion and migration required for the growth of solid cancer cells, it may be useful as a target protein for developing an anticancer agent of solid cancer.